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Abstract
Background: Parents who perceive common infant behaviors as formula intolerance-related
often switch formulas without consulting a health professional. Up to one-half of formula-fed infants
experience a formula change during the first six months of life.
Methods: The objective of this study was to assess discontinuance due to study physician-assessed
formula intolerance in healthy, term infants. Infants (335) were randomized to receive either a
standard intact cow milk protein formula (INTACT) or a partially hydrolyzed cow milk protein
formula (PH) in a 60 day non-inferiority trial. Discontinuance due to study physician-assessed
formula intolerance was the primary outcome. Secondary outcomes included number of infants
who discontinued for any reason, including parent-assessed.
Results: Formula intolerance between groups (INTACT, 12.3% vs. PH, 13.7%) was similar for
infants who completed the study or discontinued due to study physician-assessed formula
intolerance. Overall study discontinuance based on parent- vs. study physician-assessed intolerance
for all infants (14.4 vs.11.1%) was significantly different (P = 0.001).
Conclusion: This study demonstrated no difference in infant tolerance of intact vs. partially
hydrolyzed cow milk protein formulas for healthy, term infants over a 60-day feeding trial,
suggesting nonstandard partially hydrolyzed formulas are not necessary as a first-choice for healthy
infants. Parents frequently perceived infant behavior as formula intolerance, paralleling previous
reports of unnecessary formula changes.
Trial Registration: clinicaltrials.gov: NCT00666120
Background
Breastfeeding is the ideal source of nutrition for infants,
but standard cow milk-based formulas (CMBF) are an
appropriate source of nutrition for most infants who are
not breastfed [1]. Some nonstandard formulas, such as
soy-based or partially or extensively hydrolyzed protein
cow milk-based formulas (CMBF), may be indicated for
select groups of infants [2-4]. Partially hydrolyzed formu-
las are marketed as easier to digest although no evidence
supports the physical need for these formulas in healthy
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infants. In addition, healthy infants who receive a CMBF
with intact protein are often unnecessarily switched to a
nonstandard formula or alternate CMBF [5-7]. Although
published estimates of formula intolerance range from 2
to 15% [8,9], one-third to one-half of infants, however,
undergo formula change during the first 6 months of life
[5,6], implying unnecessary switching or use of nonstand-
ard formulas in healthy term infants. Rather than a pedia-
trician, parents or caregivers made 47% to 96% of
decisions to discontinue a formula based most often on
misinterpretation of common infantile behavior patterns
as formula intolerance-related [5,6].
The primary objective of this non-inferiority study was to
compare tolerance of a standard, full-lactose non-hydro-
lyzed cow milk protein formula and a 70% lactose non-
standard partially hydrolyzed whey protein formula over
a 60 day period in healthy, term infants. Non-inferiority
or equivalence studies are designed to determine if the
efficacy of new intervention matches that of a previously
used or accepted routine intervention. In this study, the
primary outcome was formula intolerance, indirectly
reflected by the number of infants who discontinued
study formula due to study physician-determined intoler-
ance, to test the hypothesis that there is no advantage in
choosing a partially hydrolyzed protein CMBF as a first-
choice formula for healthy infants. Secondary outcomes
compared between formula groups included: discontinu-
ation of study formula for any reason, including parental
assessment of formula intolerance and infant tempera-
ment using the validated Infant Characteristic Question-
naire [10].
Materials and methods
Study design
This was a multicenter, double-blind, randomized, con-
trolled, parallel, prospective, non-inferiority trial. A total
of 335 healthy, term infants were randomized to receive
one of two study formulas: a full lactose, intact cow milk
protein (60:40 whey:casein) formula supplemented with
docosahexaenoic acid (DHA) and arachidonic acid (ARA)
(INTACT; Enfamil®  LIPIL®, Mead Johnson Nutrition,
Evansville, IN) or a 70% lactose, partially hydrolyzed cow
milk protein (100:0 whey:casein) formula supplemented
with DHA and ARA (PH; Good Start® Supreme, Nestlé®
S.A., Vevey, Switzerland) over a 60 day period. INTACT is
a routine formula intended for healthy, term infants with-
out special nutritional needs and is patterned upon the
protein profile of human breast milk [11]. PH is also pro-
moted as a routine infant formula and is formulated with
partially hydrolyzed, 100% whey proteins. Outpatient vis-
its were conducted at enrollment (randomization to study
formula), day 30, and day 60; a telephone interview of the
parent or caretaker was conducted on day 45. The study
was approved by a central or site-specific Institutional
Review Board. Parents or guardians provided written
informed consent prior to study participation.
A randomization list for each study site was created by the
study sponsor using a computerized random-number
generator. Two different codes, known only to the study
sponsor, designated each study formula. Sealed envelopes
labeled with consecutive numbers contained the code of
the study formula that was to be assigned based on the
randomization list. Upon entry into the study the next
sequential numbered envelope was opened at the study
site to provide the code of the study formula to be con-
sumed by the infant. Study formula, packaged by the
study sponsor as identifiable only by its code, was then
provided to the infant.
Study population
Eligibility criteria included: term, singleton-birth infants;
birth weight of > 2500 g; 4 to 18 days of age; infants had
solely received a full-lactose, standard, intact protein
CMBF ≥ 96 hours prior to enrollment; and the mother of
the infant had no plans to breastfeed during the study.
Enrollment took place at 17 research centers and pediatric
offices throughout the United States (detailed in
Acknowledgements) between June 13, 2005, and Febru-
ary 27, 2006. Exclusion criteria included a history of
underlying metabolic or chronic disease or congenital
malformation likely to interfere with normal growth and
development; known feeding problems; switching formu-
las more than one time between birth and enrollment;
parent-reported known history of cow milk allergy in par-
ent or siblings; and use of commonly-prescribed medica-
tions for gas in infants at enrollment.
Outcomes
The primary outcome was discontinuation of assigned
study formula due to physician-assessed feeding intoler-
ance. Specified criteria for a diagnosis of formula intoler-
ance included the presence of one or more of the
following: vomiting, fussiness, allergic reaction, hunger,
constipation, diarrhea, gas, or spitting up.
Body weight, length, and head circumference were meas-
ured at enrollment. Body weight was measured again at
days 30 and 60. All other secondary outcomes were par-
ent- or caregiver- reported. Formula intake and tolerance
(spit up, crying, fussiness, gas, stool frequency, and stool
consistency) were collected using a 24 h recall question-
naire at clinic visits on days 30 and 60 and during a tele-
phone interview at day 45. Number of infants per group
who discontinued study formula due to parental assess-
ment or for any reason was collected at day 60. The
widely-used, validated Infant Characteristic Question-
naire (ICQ) [10] assessed parental perception of infant
difficultness. Fussy, difficult-to-soothe infants with irregu-Nutrition Journal 2009, 8:27 http://www.nutritionj.com/content/8/1/27
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lar behavior are often regarded as difficult. The 24-ques-
tion ICQ focuses on four subscales of infant behavior
(questions per scale): fussy-difficult (9), adaptable (5),
dull (4), and predictable (6) with the most weight given
to fussy-difficult. The ICQ subscales address infant diffi-
cultness based on fussy behavior; consequently, fussy
behavior associated with formula intolerance and poten-
tial differences in infant fussiness due to feeding regimen
were examined with this instrument. All responses were
measured on a 7-point scale (1 = optimal temperament to
7 = difficult temperament) and scores were calculated by
summing responses in each subscale. Feeding satisfaction
(parental perceptions of infant feeding behavior, feelings
of parent/caregiver regarding feeding success, and success
as a caregiver) was assessed using a 15-question Formula
Feeding Satisfaction Questionnaire (FSQ). Responses
were measured on a 7-point scale (1 = strongly agree to 7
= strongly disagree) and totaled (maximum score = 105;
some questions were reverse-coded for analysis, thus a
higher total score indicated higher formula satisfaction for
all items of the questionnaire). The FSQ and ICQ were
administered at enrollment and day 60, or if a participant
discontinued the study early. Adverse events were moni-
tored throughout the study.
Statistical analyses
In this non-inferiority study, the sample size was deter-
mined based on dropout rates reported in previous clini-
cal studies [12,13] to detect a difference in
discontinuation rate due to formula intolerance of 30%
versus 15% (α = 0.05, power = 80%). A total of 134
infants per formula group (classified as completed the
study through day 60 or discontinued due to formula
intolerance) was determined to be sufficient. Two datasets
were analyzed: 1) the per protocol dataset (D-I), included
only infants who completed the study through day 60 or
discontinued due to study physician-determined formula
intolerance; 2) secondary dataset (D-II), included all
study participants who consumed study formula. This dis-
tinction was made in order to determine the primary out-
come of discontinuation rate due to study-physician
assessment of formula intolerance excluding other rea-
sons for study discontinuance. Consequently, the
Cochran-Mantel-Haenszel test stratified by study site was
performed on the D-I dataset to compare rates of discon-
tinuation due to study physician-determined formula
intolerance and on the D-II dataset to compare rates of
discontinuation for all reasons, including parental opin-
ion of formula intolerance. The McNemar test was per-
formed on the D-II dataset to compare study physician vs.
parental opinion on whether study discontinuation was
due to formula intolerance.
Formula intake and tolerance from the 24 h recall ques-
tionnaire were compared between formula groups at day
30, day 45, and day 60. The analysis of variance model for
formula intake included study site, gender, formula
group, and gender by formula group interaction. Toler-
ance measures with continuous data included only study
site and formula group in the analysis of variance model.
Categorical data were analyzed using Fisher's exact test.
ICQ subscales were analyzed by repeated measures analy-
sis of variance. Study groups were compared at enrollment
and day 60. Comparisons were made within groups from
enrollment to day 60. Fisher's exact test was used to com-
pare the proportion of infants in each formula group with
serious adverse events during the study using the D-II
dataset.
Statistical comparisons were two-tailed and all testing was
conducted at α = 0.05. Analyses were performed by using
SAS version 9 (Cary, NC).
Results
A total of 335 infants enrolled at 17 study sites between
June 2005 and February 2006 (INTACT, 167; PH, 168);
two withdrew prior to receiving any study formula (Fig.
1). The D-I dataset included 284 infants (INTACT, n =
138; PH, n = 146) and the D-II dataset included 333
infants (INTACT, n = 165; PH, n = 168). Ten infants,
enrolled in the study and included in analyses, did not
meet the protocol inclusion criteria (INTACT, 2; PH, 8).
Two of the ten had birth weights less than the required
minimum (2500 g). One had a parent/sibling with a his-
tory of cow milk allergy. Seven did not meet the mini-
mum 38 week gestational age. Also, one of these seven
may have consumed breast milk sometime during the 96
hours prior to enrollment.
Infant characteristics are summarized in Table 1. Infants
in both formula groups were similar at enrollment for
gender, race, and anthropometrics. Study completion
rates [INTACT, 121 (73%) of 165; PH, 126 (75%) of 168;
P = 0.731], the percentage of infants who remained in the
study throughout the 60 day feeding period (Fig. 2), and
study physician-assessed formula intolerance [INTACT,
17 (12.3%) of 138; PH, 20 (13.7%) of 146; P = 0.812, D-
I dataset; 95% CI, -9.3% to 6.5%] (Fig. 1) were similar
between groups. Consequently, there was no significant
difference between groups in discontinuance for the pri-
mary outcome of study physician-assessed formula intol-
erance. Of the 37 infants who discontinued due to
physician-assessed formula intolerance, the main symp-
toms reported were fussiness (n = 11 vs. 15), gas (n = 11
vs. 14), spitting up (n = 4 vs. 8), vomiting (n = 2 vs. 4), and
constipation (n = 2 vs. 3) for INTACT vs. PH, respectively.
However, overall study discontinuance based on study
physician-assessed versus parent-assessed formula intoler-
ance [37 (11.1%) of 333 vs. 48 (14.4%) of 333] for all
infants was significantly different (P = 0.001, D-II data-Nutrition Journal 2009, 8:27 http://www.nutritionj.com/content/8/1/27
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set). That is, more parents deemed their infants to be feed-
ing intolerant than did their physicians.
No significant differences in weight were observed
between groups at days 30 or 60 (data not shown). Paren-
tal 24 h recall of infant formula intake and tolerance
measures at days 30, 45 and 60 were similar (data not
shown) with the exception of stool frequency at day 60
(1.9/day, INTACT vs. 2.2/day, PH; P = 0.022, D-I and D-II
datasets). Low incidence of constipation or diarrhea was
similar for both feeding groups (0 – 6% infants affected at
any time). Means for ICQ infant temperament subscales
(D-I and D-II datasets) were similar between groups at
enrollment and study end (day 60 or day of study discon-
tinuation; Table 2). In this healthy infant population,
fussy-difficult ICQ scores, in particular, were similar and
below mid-range within study groups from enrollment to
study end. However, INTACT adaptability scores at study
end (ex: reactions to new people, disruptions, bath-time)
were significantly lower (better) than at enrollment.
INTACT and PH dullness scores at study end (ex: smiling,
excitement in play, activity) were also significantly lower
than at enrollment. Because a lower ICQ score is closer to
optimal behavior it is not surprising that scores in these
areas improved with infant age by the end of the feeding
trial. Means (± SE) for parental FSQ total scores (maxi-
Flow of study participants Figure 1
Flow of study participants.
INTACT (n = 167) 
Randomized to study formula
(n = 335) 
INTACT
Completed 
(n = 121) 
PH (n = 168) 
 Withdrawn:
 2  Received no study formula  0 
PH
Completed
(n = 126) 
INTACT (n = 165) 
D-II dataset 
PH (n = 168) 
D-II dataset 
(n = 44)  Discontinued:   (n = 42) 
9  Lost to follow-up  5 
18  Other reasons (not study physician-assessed)  17 
17  Formula intolerance (study physician-assessed) 20 
INTACT (n = 138) 
D-I dataset 
PH (n = 146) 
D-I dataset 
Table 1: Infant characteristics at enrollment
INTACT PH
Weight, g* 3571.4 ± 51.15 3533.5 ± 52.17
Length, cm* 51.4 ± 0.23 51.1 ± 0.24
Head circumference, cm* 35.8 ± 0.15 35.7 ± 0.15
Gender, n
Male 94 91
Female 71 77
Race, n
White 115 127
Black 38 27
Other 12 14
* Mean ± standard error (SE)Nutrition Journal 2009, 8:27 http://www.nutritionj.com/content/8/1/27
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mum possible total score = 105) were similar between
groups at enrollment (INTACT, 95.8 ± 1.3; PH, 97.1 ± 1.3)
and study end (INTACT, 91.9 ± 1.3; PH, 93.2 ± 1.3). Par-
ents were equally and highly-satisfied with fully intact
CMBF formulas at enrollment, (i.e., before study formulas
were administered) and with both INTACT and PH by
study end.
There were no differences in frequency of serious adverse
events between formula groups (INTACT, 5/165; PH, 5/
168). Serious adverse events for the INTACT group
included: cervical lymph adenitis abscess secondary to
Staphylococcus aureus infection, seizure, respiratory syncy-
tial virus with bronchiolitis, pyloric stenosis, and an
apparent life-threatening event (n = 1 per event). Serious
adverse events for the PH group included: respiratory syn-
cytial virus, sudden infant death syndrome, moderate gas-
troesophageal reflux, jaundice and sepsis, and pyloric
stenosis (n = 1 per event). All events were judged as unre-
lated to study formula intake.
Percentage of infants that continued to consume INTACT formula (full line) or PH formula (dashed line) from enrollment (day  1 of study) to day 60 Figure 2
Percentage of infants that continued to consume INTACT formula (full line) or PH formula (dashed line) from 
enrollment (day 1 of study) to day 60.
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Table 2: Parental perception of infant temperament :  Assessment using the Infant Characteristics Questionnaire (ICQ)* at 
enrollment and study end†
ICQ subscale§ enrollment‡ study end‡
INTACT PH INTACT PH
Fussy-difficult 25.6 ± 0.79 24.7 ± 0.80 25.5 ± 0.81 25.8 ± 0.82
Adaptable 11.8 ± 0.50 11.6 ± 0.51 10.4 ± 0.51a 10.9 ± 0.52
Dull 14.8 ± 0.45 15.3 ± 0.46 9.8 ± 0.47b 10.2 ± 0.47b
Predictable 16.7 ± 0.54 16.6 ± 0.54 16.0 ± 0.55 16.4 ± 0.56
* A lower ICQ score is closer to optimal behavior
† Study end: day 60 (study completion) or early study discontinuation at any time point
‡ Comparisons at time-points between study groups for ICQ subscale were not statistically significant, P > 0.05.
§Least square means ± SE
a score at enrollment vs. day 60, P = 0.001
b score at enrollment vs. day 60, P < 0.001Nutrition Journal 2009, 8:27 http://www.nutritionj.com/content/8/1/27
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Discussion
The present non-inferiority study demonstrated no signif-
icant differences in study discontinuance between infants
in the INTACT or PH group based on study physician-
assessed formula intolerance over a 60-day feeding trial.
Thus, this study indicated that formula tolerance was sim-
ilar in healthy term infants who received an intact cow
milk protein formula or a partially hydrolyzed cow milk
protein formula. Using formula discontinuation as an
indirect marker of intolerance, this study demonstrated
healthy, term infants gained no advantage by receiving a
CMBF with partially hydrolyzed whey protein instead of a
standard, intact protein CMBF patterned closely on the
protein profile of human milk. Other than a difference in
stool frequency, groups were similar for infant formula
intake, weight, and tolerance (hours of crying, fussiness,
gas, stool consistency, and incidence of diarrhea and con-
stipation). Parent-reported FSQ (feeding satisfaction) and
all four ICQ temperament subscales were also similar
between groups at all measured time-points, indicating
comparable formula tolerance for both INTACT and PH
groups.
A significant difference in study physician- versus parent-
assessed opinion of formula intolerance was noted for all
infants randomized to either formula. The results are con-
sistent with reports that parents often discontinue use of a
particular formula for reasons other than pediatrician-
assessed symptoms associated with formula intolerance.
The statistical methods used in this study, including the
large number of participants and multi-center design,
were adequate to detect this small but significant differ-
ence in formula tolerance assessment. Results of this study
were similar to previous reports of infant feeding toler-
ance and formula changes in early infancy [5-7]. In one
survey, formulas were changed in over 30% of infants
with parent-reported feeding-related issues such as colic,
excessive crying, or belief that an infant had a cow milk
allergy [7]. In another, parental decision to discontinue a
particular formula, rather than a physician or other health
care provider, occurred in 47% of infants [6]. Pediatri-
cians were involved in only 4% of decisions to switch for-
mulas in another study where 47% of infants underwent
discontinuation of at least one formula within the first 6
months of life [5].
Normal feeding and adaptation between infant and car-
egiver during the first few weeks of life includes common
episodes of regurgitation, crying, fussiness, and colic
regardless of feeding regimen [14-17]. Daily regurgitation
is reported in up to one-half of infants [14,15]. In a study
of infant crying, colic, spit-ups, and feeding difficulties,
35% percent of mothers reported moderate or severe
problems in the early postnatal period [16]. Such behav-
iors in early infancy may be erroneously parent-labeled as
formula intolerance and drive the parent to discontinue
an infant formula. Other non-behavioral or non-medical
factors may also impact parental decisions to change for-
mulas: family or friends' recommendations, parent
returning to work, formula cost, or media influence.
Manufacturers of partially hydrolyzed formulas often
advertise products as easier to digest. For example, infants
fed a whey protein hydrolysate formula had faster gastric
emptying compared with infants fed traditional whey-pre-
dominant or casein-predominant formulas [18]; how-
ever, faster gastric emptying may not equal easier
digestion. Kinetics play a major role in dietary nitrogen
utilization and slower digestion of milk protein fractions
may induce better postprandial nitrogen utilization [19].
In the present study, infants eligible at enrollment solely
received a standard, full-lactose, intact protein CMBF for
at least 96 hours prior to randomization to INTACT or PH
groups. Parental ICQ temperament scores and total feed-
ing satisfaction (FSQ scores) were similar for both groups
at enrollment – before an assessment of INTACT vs. PH
was undertaken – and at day 60. Fussy-difficult scores in
this healthy population did not change from enrollment
to study end (day 60 or day of study discontinuation) in
either study group. Barring subsequent indications of fuss-
iness or formula intolerance, results from our study sug-
gest that within a normal, healthy infant population there
is no need to use a partially hydrolyzed formula instead of
a standard CMBF. Given the results from this study and
the increased cost of nonstandard formulas [4], suggesting
the use of nonstandard partially hydrolyzed formulas may
not be appropriate for normal, healthy infants. A recent
study demonstrated that feeding a partially hydrolyzed,
low-lactose formula resolved symptoms in an infant pop-
ulation identified by fussy behavior [20]. Recommenda-
tions for the use of partially hydrolyzed formulas should
be supported by clinical studies within the intended
infant population. Further investigation and confirmation
of partially hydrolyzed formula's effect on a fussy infant
population is warranted.
Conclusion
This study demonstrated no difference in tolerance of
standard intact cow milk protein formula compared with
partially hydrolyzed cow milk protein formula for
healthy, term infants over a 60-day feeding period. A sig-
nificant difference between study physician- and parent-
assessed formula intolerance was observed, indicating
parents discontinued formula for reasons other than for-
mula intolerance. This conclusion parallels earlier reports
that parents mistake behaviors common in early infancy
(regurgitation, excessive crying, etc.) as manifestations of
formula intolerance and unnecessarily switch formulas,
often to non-standard formulas. Nonstandard formulas,
such as partially hydrolyzed formulas, may be appropriatePublish with BioMed Central    and   every 
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for a targeted group of individuals rather than as a first-
choice formula best-suited for a healthy infant popula-
tion.
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